24

DAFTAR PUSTAKA

1. Piraccini BM and Alessandrini. Onychomycosis: A Review. J Fungi 2015; 1: 30-43.

2. Arndt KA, LeBoit PE, Wintroub BU. Onychomychosis : Diagnosis, Treatment, and
Prevention Strategies. Semin Cutaneus Medicine and Surgery 2016; 12 (1Suppl 3):
53-62.

3. Gelotar P, Vachhani S, Patel B, Makwana N. The Prevalence of Fingernail

Onychomycosis. J Clinical and Diagnostic Research 2013;7:250-2.

4. Scher RK, Rich P, Pariser D, Elewski B. The Epidemiology, Etyology, and

Pathophysiology of Onychomycosis. Semin Cutan Med Surg 2013; 32(2 suppl 1):
52-4.

5. Klaassen KM, Dulak MG, Van de Kerkhof PC, Paasch MC. The Prevalence of
Onychomycosis in Psoriatic Patients: A systematic review. J Eur Acad Dermatol
Venereol 2014;28:533-41.

6. Winston JA, and Miller JL. Treatment of Onychomycosis in Diabetic Patients. Clin
Diabetes 2006;24:160-6.

7. Wulkan AJ, and Tosti A. Pediatric Nail Conditions. Clin. Dermatol 2013;31:564–72.

8. Elewski BE. Onychomycosis: Pathogenesis, Diagnosis, and Management. Clinical

Microbiology Reviews 1998;11:415-29.

9. Piraccini BM, and Tosti A. White Superficial Onychomycosis: Epidemiological,

Clinical, and Pathological Study of 79 Patients. Arch Dermatol 2004; 140 :696–701.

10. Ameen M, Lear JT, Madan V, Mohd Mustapa MF, Richardson M. British Association
of Dermatologists’ Guidelines for The Management of Onychomycosis 2014. Br J
Dermatol. 2014; 171:937–58
.
11. Roberts D.T, Taylor W.D, Boyle J. Guidelines for Treatment of Onychomycosis.
British Journal of Dermatology 2003; 148:402–10.

12. Gupta AK, Fleckman P, Baran R. Ciclopirox Nail Lacquer Topical Solution 8% in
The Treatment of Toenail Onychomycosis. J Am Acad Dermatol. 2000;43(4
Suppl):70–80.

13. Gupta AK, Ryder JE, Johnson AM. Cumulative Meta-Analysis of Systemic
Antifungal Agents for The Treatment of Onychomycosis. Br J Dermatol.
2004;150(3):537–44.
 24

14. Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H, et al.
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase
III multicenter, randomized, double-blind studies. J Am Acad Dermatol. 2013;68 :
600–8.

15. Bueno JG, Martinez C, Zapata B, Sanclemente G, Gallego M, Mesa AC. In vitro
Activity of Fluconazole, Itraconazole, Voriconazole and Terbinafine Against Fungi
Causing Onychomycosis. Clin Exp Dermatol. 2010;35:658–63.

16. Volk B, Tiu A, Anna LS. Clinical Inquiries: Evidence-based answers from the Family
Physicians Inquiries Network, Which oral antifungal works Best for Toenail
Onychomycosis. J. Fam. Pract. 2013;62(2):100-01

17. De Sa, D.C, Lamas, A.P, Tosti A,. Oral Therapy for Onychomychosis: An Evidence-
Based Review. Am. J. Clin. Dermatol. 2014;15:17-36.

18. Gupta A.K, Paquet M, Simpson F, Tavakkol A. Terbinafine in the Treatment of

Dermatophyte Toenail Onychomychosis: A Meta-Analysis of Efficacy for Continous
and Intermittent Regiens. J. Eur. Acad. Dermatol. Venerol. 2013;27:267-72.

19. Gupta A.K, Gover M.D, Lynde C.W. Pulse Itraconazole vs Continous Terbinafine for
The Treatment of Dermatophye Toenali Onychomycosis in Patients with Diabetes
Mellitus. J. Eur. Acad. Dermatol. Venerol. 2006;20:1188-93.

20. Gupta A.K, Drummond-Main C, Paquet M. Evidence-Based Optimal Fluconazole

Dosing Regimen for Onychomicosis Treatment. J. Dermatol. Treat. 2013;23:75-80.

21. Figueiredo Souza L.W, Soiza S.V, Botelho A.C. Randomized Controlled Trial
Comparing Photodynamic Therapy Based on Methylene Blue Dye and Fluconazole
for Toenail Onychomycosis. Dermatol. Ther. 2014;27:43-7.

22. Evans E.G, Sigurgeirsson B. Double-Blind, Randomized Study of Continuous

Terbinafine Compared with Intermittent Itraconazole in Treatment of Toenail
Onychomycosis. BMJ. 1999;318:1031-5.

23. Havu V, Heikkila H, Kuokkanen K. A Double-Blind, Randomized Study to Compare

The Efficacy and Safety of Terbinafine with Fluconazole in The Treatment of
Onychomycosis. Br J Dermatol. 2000;142:97-102.

24. Warshaw E.M, Fett D.D, Bloomfield H.E. Pulse Versus Continuous Terbinafine for
Onychomycosis: A Randomized, Double-Blind, Controlled Trial. J Am Acad
Dermatol. 2005; 53:578-584.

25. Sigurgeirsson B, Elewski B.E, Rich P.A. Intermittent Versus Continuous Terbinafine
in The Treatment of Toenail Onychomycosis: A Randomized, Double-Blind
Comparison. J Dermatol Treat. 2006;17:38-44.
 23

26. Piraccini B. M, Sisti A, Tosti A. Long-Term Follow-up of Toenail Onychomycosis

Caused by Dermatophytes After Successful Treatment with Systemic Antifungal
Agents. J Am Acad Dermatol. 2010;62:411-4.